Neuromod Names New CSO To Complete TENT-A Tinnitus Trial And Advance Noninvasive Neuromodulation Platform
Executive Summary
Neuromod, a Dublin, Ireland-based emerging medical technology firm focusing on noninvasive neuromodulation technologies, has named neurostimulation expert Hubert Lim as its new CSO to conclude the company's TENT-A tinnitus trial in Ireland and Germany.